Delivery Order SPE2DB22D3016-SPE2DB25FAUS3
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $44K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $27,011.21 to AmerisourceBergen Drug Corp for the supply of Neulasta OnPro 6 mg/0.6 ml kits on August 29, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader relationship with the federal government. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $11,686.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $18.7K to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Neulasta OnPro 6 mg/0.6 mL kits. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Neulasta is a specialty pharmaceutical product used to support patient recovery following chemotherapy...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 25, 2025, procures Neulasta OnPro 6 mg/0.6 mL kits valued at $14,023.92 through a firm fixed-price contract with the Defense Logistics Agency (DLA). The contract requires completion by August 26, 2025, and represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical needs. Neulasta is a specialty medication used for chemotherapy-related side effects, and this procurement leverages...
- This is a $2,465.76 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's global military treatment programs and...
- The Defense Logistics Agency awarded a $28,076.54 delivery order to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $10,026.36 for Neulasta 6 mg/0.6 mL syringes, with completion targeted for August 7, 2025. The contract, issued on August 6, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...